HR 3199
Term Act of 2019
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Terminating the Extension of Rights Misappropriated Act of 2019, aims to prevent ‘double patenting’ for drugs. It requires companies holding multiple patents covering the same drug to prove each patent covers a distinct invention. If they fail to do so, the patents will be effectively disclaimed, meaning their patent term extensions will be revoked. The bill also directs the USPTO to review its examination procedures to prevent the issuance of multiple patents for the same drug unless they cover distinct inventions, and to report its findings to Congress.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.